11th International Symposium on Neuroprotection & Neurorepair 2024

🌟 Highlights from Neurorepair 2024 conference 🌟

This week, Lys Therapeutics had the privilege of participating in the Neurorepair 2024 Conference (neurorepair-2024.com), an incredible gathering of leading minds in neurodegenerative and neurovascular disease research.

We were thrilled to showcase two poster presentations, led by our very own Dr. Fanny Potzeha, highlighting the groundbreaking potential of LYS241 in addressing critical unmet medical needs in ischemic stroke and Parkinson’s disease:

🧠 Stroke:
“LYS241: A Novel Therapeutic Targeting tPA-NMDAR Interaction for the Treatment of Ischemic Stroke”

🧠 Parkinson’s Disease:
“A Novel Therapeutic for the Treatment of Parkinson’s Disease Targeting the tPA-NMDAR Interaction”

These presentations underscore Lys Therapeutics’ dedication to innovative solutions that could transform the treatment landscape for patients worldwide.

Thank you to the Neurorepair 2024 organizers for hosting such an inspiring event and to the scientific community for engaging with our research. We are more committed than ever to advancing the fight against neurological diseases.